Relationship Between Azithromycin and Cardiovascular Outcomes in Unvaccinated Patients With COVID‐19 and Preexisting Cardiovascular Disease

BACKGROUND: Empiric antimicrobial therapy with azithromycin is highly used in patients admitted to the hospital with COVID‐19, despite prior research suggesting that azithromycin may be associated with increased risk of cardiovascular events. METHODS AND RESULTS: This study was conducted using data...

Descripción completa

Detalles Bibliográficos
Autores principales: Bergami, Maria, Manfrini, Olivia, Nava, Stefano, Caramori, Gaetano, Yoon, Jinsung, Badimon, Lina, Cenko, Edina, David, Antonio, Demiri, Ilir, Dorobantu, Maria, Fabin, Natalia, Gheorghe‐Fronea, Oana, Jankovic, Radmilo, Kedev, Sasko, Ladjevic, Nebojsa, Lasica, Ratko, Loncar, Goran, Mancuso, Giuseppe, Mendieta, Guiomar, Miličić, Davor, Mjehović, Petra, Pašalić, Marijan, Petrović, Milovan, Poposka, Lidija, Scarpone, Marialuisa, Stefanovic, Milena, van der Schaar, Mihaela, Vasiljevic, Zorana, Vavlukis, Marija, Vega Pittao, Maria Laura, Vukomanovic, Vladan, Zdravkovic, Marija, Bugiardini, Raffaele
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10382084/
https://www.ncbi.nlm.nih.gov/pubmed/37449568
http://dx.doi.org/10.1161/JAHA.122.028939

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10382084/
https://www.ncbi.nlm.nih.gov/pubmed/37449568
http://dx.doi.org/10.1161/JAHA.122.028939

Ejemplares similares